Perrigo Co. Plc is a pure-play self-care company provider of consumer self-care products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. The company is headquartered in Dublin, Dublin and currently employs 8,379 full-time employees. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. The company primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.
Follow-Up Questions
Who is the CEO of Perrigo Company PLC?
Mr. Patrick Lockwood-Taylor is the President of Perrigo Company PLC, joining the firm since 2023.
What is the price performance of PRGO stock?
The current price of PRGO is $20.5, it has decreased 0.12% in the last trading day.
What are the primary business themes or industries for Perrigo Company PLC?
Perrigo Company PLC belongs to Pharmaceuticals industry and the sector is Health Care
What is Perrigo Company PLC market cap?
Perrigo Company PLC's current market cap is $2.8B
Is Perrigo Company PLC a buy, sell, or hold?
According to wall street analysts, 5 analysts have made analyst ratings for Perrigo Company PLC, including 2 strong buy, 5 buy, 3 hold, 0 sell, and 2 strong sell
